A review of therapeutic agents for the management of pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening disease characterized by a proliferative vasculopathy of the small muscular pulmonary arterioles resulting in elevated pulmonary vascular resistance and eventually right ventricular failure. An increasing understa...
Main Authors: | Stella S Hahn, Mina Makaryus, Arunabh Talwar, Mangala Narasimhan, Gulrukh Zaidi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465816665289 |
Similar Items
-
Enlarged pulmonary artery on computed tomography and respiratory failure in sickle cell disease acute chest syndrome
by: Joseph L. Simonson, et al.
Published: (2021-05-01) -
Depression in pulmonary arterial hypertension: An undertreated comorbidity
by: Sameer Verma, et al.
Published: (2016-01-01) -
Ultrasound for the Pulmonary Consultant
by: Astha Chichra, et al.
Published: (2016-01-01) -
Pulmonary artery aneurysm: a review
by: Mridul Gupta, et al.
Published: (2020-02-01) -
Review: Therapeutic advances in pulmonary arterial hypertension
by: K. Boutet, et al.
Published: (2008-08-01)